{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:29:31Z","timestamp":1790612971724,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cellular Signalling"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.cellsig.2026.112410","type":"journal-article","created":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T00:33:08Z","timestamp":1770424388000},"page":"112410","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["USP14 and ELAVL1-induced stabilization of VDAC1 aggravates myocardial cell injury in diabetic cardiomyopathy"],"prefix":"10.1016","volume":"143","author":[{"given":"Yueru","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhikai","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.cellsig.2026.112410_bb0005","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/ehf2.14224","article-title":"Diabetic cardiomyopathy: a brief summary on lipid toxicity","volume":"10","author":"Ke","year":"2023","journal-title":"ESC Heart Fail."},{"issue":"17","key":"10.1016\/j.cellsig.2026.112410_bb0010","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25179481","article-title":"Diabetic cardiomyopathy: role of cell death, exosomes, fibrosis and Epicardial adipose tissue","volume":"25","author":"Galeone","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112410_bb0015","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2174\/0118744710312688240814100448","article-title":"Left ventricular wall motion as an additional valuable parameter in diabetic patients with normal myocardial perfusion imaging","volume":"18","author":"Amirhesam","year":"2025","journal-title":"Curr. Radiopharm."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112410_bb0020","doi-asserted-by":"crossref","first-page":"268","DOI":"10.2174\/1871530320666200731174724","article-title":"Diabetic cardiomyopathy: from mechanism to Management in a Nutshell","volume":"21","author":"Khan","year":"2021","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"issue":"6","key":"10.1016\/j.cellsig.2026.112410_bb0025","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/jdi.12250","article-title":"Diabetic cardiomyopathy and its mechanisms: role of oxidative stress and damage","volume":"5","author":"Liu","year":"2014","journal-title":"J. Diabet. Invest."},{"key":"10.1016\/j.cellsig.2026.112410_bb0030","article-title":"Empagliflozin mitigates high glucose-disrupted mitochondrial respiratory function in H9c2 Cardiomyoblasts: a comparative study with NHE-1 and ROCK inhibition","volume":"17","author":"Cheng","year":"2024","journal-title":"Curr. Mol. Pharmacol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112410_bb0035","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.apsb.2021.08.026","article-title":"Preliminary evidence for the presence of multiple forms of cell death in diabetes cardiomyopathy","volume":"12","author":"Wei","year":"2022","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.cellsig.2026.112410_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3389\/fphar.2020.00042","article-title":"Distinct types of cell death and the implication in diabetic cardiomyopathy","volume":"11","author":"Chen","year":"2020","journal-title":"Front. Pharmacol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112410_bb0045","doi-asserted-by":"crossref","DOI":"10.3390\/biom10111485","article-title":"VDAC1 at the intersection of cell metabolism, apoptosis, and diseases","volume":"10","author":"Shoshan-Barmatz","year":"2020","journal-title":"Biomolecules"},{"issue":"19","key":"10.1016\/j.cellsig.2026.112410_bb0050","doi-asserted-by":"crossref","DOI":"10.3390\/cells11193174","article-title":"Mitochondrial VDAC1: a potential therapeutic target of inflammation-related diseases and clinical opportunities","volume":"11","author":"Hu","year":"2022","journal-title":"Cells"},{"issue":"1","key":"10.1016\/j.cellsig.2026.112410_bb0055","article-title":"MicroRNA-7a-5p ameliorates diabetic peripheral neuropathy by regulating VDAC1\/JNK\/c-JUN pathway","volume":"40","author":"Jiao","year":"2023","journal-title":"Diabet Med.\u202f: J. Br. Diabet. Assoc."},{"key":"10.1016\/j.cellsig.2026.112410_bb0060","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jprot.2013.10.037","article-title":"Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis","volume":"96","author":"Zubiri","year":"2014","journal-title":"J. Proteome"},{"issue":"20","key":"10.1016\/j.cellsig.2026.112410_bb0065","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21207432","article-title":"Role of TSPO\/VDAC1 upregulation and matrix Metalloproteinase-2 localization in the dysfunctional myocardium of hyperglycaemic rats","volume":"21","author":"Gliozzi","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.cellsig.2026.112410_bb0070","doi-asserted-by":"crossref","first-page":"36340","DOI":"10.1038\/srep36340","article-title":"lncRNA H19\/miR-675 axis regulates cardiomyocyte apoptosis by targeting VDAC1 in diabetic cardiomyopathy","volume":"6","author":"Li","year":"2016","journal-title":"Sci. Rep."},{"issue":"5","key":"10.1016\/j.cellsig.2026.112410_bb0075","first-page":"543","article-title":"Identification of a ubiquitination-related signature for ovarian cancer based on 101 combinations of machine learning methods","volume":"21","author":"Miao","year":"2024","journal-title":"Curr. Proteomics"},{"issue":"2","key":"10.1016\/j.cellsig.2026.112410_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.curpro.2025.100016","article-title":"Exploration of atractylenolide III targeting MDM2\/p53 axis in breast cancer cell progression based on network pharmacology, molecular docking and ubiquitination analysis","volume":"22","author":"Zou","year":"2025","journal-title":"Curr. Proteomics"},{"key":"10.1016\/j.cellsig.2026.112410_bb0085","article-title":"USP14: structure, function, and target inhibition","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Pharmacol."},{"issue":"12","key":"10.1016\/j.cellsig.2026.112410_bb0090","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.2174\/1570180820666230607102138","article-title":"Gardenin B, A Natural Inhibitor for USP7: <i>In vitro<\/i> Evaluation and <i>In silico<\/i> Identification","volume":"21","author":"Siyu","year":"2024","journal-title":"Lett. Drug Des. Discov."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112410_bb0095","doi-asserted-by":"crossref","first-page":"5644","DOI":"10.1038\/s41467-022-33285-x","article-title":"USP14 promotes tryptophan metabolism and immune suppression by stabilizing IDO1 in colorectal cancer","volume":"13","author":"Shi","year":"2022","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.cellsig.2026.112410_bb0100","doi-asserted-by":"crossref","first-page":"4299","DOI":"10.1007\/s12010-025-05215-2","article-title":"USP14-dependent IGF1R aggravates high glucose-induced diabetic retinopathy by upregulating BAP1","volume":"197","author":"Yu","year":"2025","journal-title":"Appl. Biochem. Biotechnol."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112410_bb0105","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12933-024-02541-3","article-title":"NLRP3 inflammasome-modulated angiogenic function of EPC via PI3K\/ Akt\/mTOR pathway in diabetic myocardial infarction","volume":"24","author":"Li","year":"2025","journal-title":"Cardiovasc. Diabetol."},{"issue":"8","key":"10.1016\/j.cellsig.2026.112410_bb0110","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109178","article-title":"ELAVL1 primarily couples mRNA stability with the 3\u2019 UTRs of interferon-stimulated genes","volume":"35","author":"Rothamel","year":"2021","journal-title":"Cell Rep."},{"issue":"3","key":"10.1016\/j.cellsig.2026.112410_bb0115","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/MOH.0000000000000040","article-title":"Post-transcriptional gene regulation by HuR and microRNAs in angiogenesis","volume":"21","author":"Chang","year":"2014","journal-title":"Curr. Opin. Hematol."},{"key":"10.1016\/j.cellsig.2026.112410_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2023.121534","article-title":"Proteomic profiling and ROC analysis identify CD151 and ELAVL1 as potential therapy response markers for the antiviral drug in resistant TNBC","volume":"320","author":"Marni","year":"2023","journal-title":"Life Sci."},{"key":"10.1016\/j.cellsig.2026.112410_bb0125","doi-asserted-by":"crossref","DOI":"10.1016\/j.neo.2024.101049","article-title":"ELAVL1 regulates PD-L1 mRNA stability to disrupt the infiltration of CD4-positive T cells in prostate cancer","volume":"57","author":"Cai","year":"2024","journal-title":"Neoplasia (New York, NY)"},{"issue":"9","key":"10.1016\/j.cellsig.2026.112410_bb0130","article-title":"Up-regulation of miR-192-5p inhibits the ELAVL1\/PI3K\u03b4 axis and attenuates microvascular endothelial cell proliferation, migration and angiogenesis in diabetic retinopathy","volume":"40","author":"Fu","year":"2023","journal-title":"Diabet Med.\u202f: J. Br. Diabet. Assoc."},{"key":"10.1016\/j.cellsig.2026.112410_bb0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.tice.2025.103060","article-title":"ELAVL1 promotes ferroptosis-induced inhibition of osteogenic differentiation in diabetic osteoporosis by downregulating SIRT1","volume":"97","author":"Huang","year":"2025","journal-title":"Tissue Cell"},{"issue":"4","key":"10.1016\/j.cellsig.2026.112410_bb0140","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.bbrc.2016.02.065","article-title":"MicroRNA-9 inhibits hyperglycemia-induced pyroptosis in human ventricular cardiomyocytes by targeting ELAVL1","volume":"471","author":"Jeyabal","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.cellsig.2026.112410_bb0145","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.coph.2020.08.015","article-title":"Disruption of energy utilization in diabetic cardiomyopathy; a mini review","volume":"54","author":"Nirengi","year":"2020","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.cellsig.2026.112410_bb0150","article-title":"Profile of crosstalk between glucose and lipid metabolic disturbance and diabetic cardiomyopathy: inflammation and oxidative stress","volume":"13","author":"Chen","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.cellsig.2026.112410_bb0155","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.ijcard.2022.12.003","article-title":"Ferulic acid attenuates high glucose-induced MAM alterations via PACS2\/IP3R2\/FUNDC1\/VDAC1 pathway activating proapoptotic proteins and ameliorates cardiomyopathy in diabetic rats","volume":"372","author":"Salin Raj","year":"2023","journal-title":"Int. J. Cardiol."},{"issue":"11","key":"10.1016\/j.cellsig.2026.112410_bb0160","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41419-024-07216-1","article-title":"Inhibition of VDAC1 oligomerization blocks cysteine deprivation-induced ferroptosis via mitochondrial ROS suppression","volume":"15","author":"Jang","year":"2024","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.cellsig.2026.112410_bb0165","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1038\/s41418-022-01094-w","article-title":"Mitochondria and cell death-associated inflammation","volume":"30","author":"Vringer","year":"2023","journal-title":"Cell Death Differ."},{"issue":"1","key":"10.1016\/j.cellsig.2026.112410_bb0170","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010449","article-title":"Lipid peroxidation and Iron metabolism: two corner stones in the homeostasis control of Ferroptosis","volume":"24","author":"Rochette","year":"2022","journal-title":"Int. J. Mol. Sci."}],"container-title":["Cellular Signalling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000604?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0898656826000604?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T22:58:11Z","timestamp":1775602691000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0898656826000604"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":34,"alternative-id":["S0898656826000604"],"URL":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112410","relation":{},"ISSN":["0898-6568"],"issn-type":[{"value":"0898-6568","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP14 and ELAVL1-induced stabilization of VDAC1 aggravates myocardial cell injury in diabetic cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"Cellular Signalling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cellsig.2026.112410","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112410"}}